Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.
Golkaram M, Kuo F, Gupta S, Carlo MI, Salmans ML, Vijayaraghavan R, Tang C, Makarov V, Rappold P, Blum KA, Zhao C, Mehio R, Zhang S, Godsey J, Pawlowski T, DiNatale RG, Morris LGT, Durack J, Russo P, Kotecha RR, Coleman J, Chen YB, Reuter VE, Motzer RJ, Voss MH, Liu L, Reznik E, Chan TA, Hakimi AA. Golkaram M, et al. Among authors: rappold p. Genome Med. 2022 Dec 19;14(1):143. doi: 10.1186/s13073-022-01146-3. Genome Med. 2022. PMID: 36536472 Free PMC article.
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors.
Khaleel S, Perera M, Papa N, Kuo F, Golkaram M, Rappold P, Kotecha RR, Coleman J, Russo P, Motzer R, Reznik E, Hakimi AA. Khaleel S, et al. Among authors: rappold p. Urol Oncol. 2024 Nov 12:S1078-1439(24)00694-X. doi: 10.1016/j.urolonc.2024.10.013. Online ahead of print. Urol Oncol. 2024. PMID: 39537440
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.
Chakiryan NH, Kim Y, Berglund A, Chang A, Kimmel GJ, Hajiran A, Nguyen J, Moran-Segura C, Saeed-Vafa D, Katende EN, Lopez-Blanco N, Chahoud J, Rappold P, Spiess PE, Fournier M, Jeong D, Wang L, Teer JK, Dhillon J, Kuo F, Hakimi AA, Altrock PM, Mulé JJ, Manley BJ. Chakiryan NH, et al. Among authors: rappold p. J Immunother Cancer. 2023 Apr;11(4):e006195. doi: 10.1136/jitc-2022-006195. J Immunother Cancer. 2023. PMID: 37185232 Free PMC article.
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.
Rappold PM, Vuong L, Leibold J, Chakiryan NH, Curry M, Kuo F, Sabio E, Jiang H, Nixon BG, Liu M, Berglund AE, Silagy AW, Mascareno EA, Golkaram M, Marker M, Reising A, Savchenko A, Millholland J, Chen YB, Russo P, Coleman J, Reznik E, Manley BJ, Ostrovnaya I, Makarov V, DiNatale RG, Blum KA, Ma X, Chowell D, Li MO, Solit DB, Lowe SW, Chan TA, Motzer RJ, Voss MH, Hakimi AA. Rappold PM, et al. Cancer Discov. 2022 Oct 5;12(10):2308-2329. doi: 10.1158/2159-8290.CD-21-0925. Cancer Discov. 2022. PMID: 35758895 Free PMC article. Clinical Trial.
Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma.
Silagy AW, Tin AL, Rappold P, Vertosick EA, Mano R, Attalla K, Yoo A, Weng S, DiNatale RG, Vickers AJ, Sjoberg DD, Coleman JA, Russo P, Hakimi AA. Silagy AW, et al. Among authors: rappold p. Clin Genitourin Cancer. 2022 Oct;20(5):e432-e439. doi: 10.1016/j.clgc.2022.05.010. Epub 2022 May 25. Clin Genitourin Cancer. 2022. PMID: 35753989 Free PMC article.
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A, Tang C, Zucker M, Fitzgerald K, DiNatale RG, Rappold PM, Weiss K, Freeman B, Lee CH, Schultz N, Motzer R, Russo P, Coleman J, Reuter VE, Chen YB, Carlo MI, Gill AJ, Kotecha RR, Ari Hakimi A, Reznik E. Yoo A, et al. Among authors: rappold pm. Eur Urol Focus. 2022 Sep;8(5):1278-1288. doi: 10.1016/j.euf.2021.12.002. Epub 2022 Mar 11. Eur Urol Focus. 2022. PMID: 35288096 Free PMC article.
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.
Attalla K, DiNatale RG, Rappold PM, Fong CJ, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Durack JC, Solomon SB, Reuter VE, Russo P, Chan TA, Motzer RJ, Schultz ND, Reznik E, Voss MH, Hakimi AA. Attalla K, et al. Among authors: rappold pm. Clin Cancer Res. 2021 Oct 15;27(20):5595-5606. doi: 10.1158/1078-0432.CCR-20-4058. Epub 2021 Jul 14. Clin Cancer Res. 2021. PMID: 34261695 Free PMC article.
Immune checkpoint blockade in renal cell carcinoma.
Rappold PM, Silagy AW, Kotecha RR, Hakimi AA. Rappold PM, et al. J Surg Oncol. 2021 Mar;123(3):739-750. doi: 10.1002/jso.26339. J Surg Oncol. 2021. PMID: 33595892 Free PMC article. Review.
21 results